Navigation Links
H1N1 Pandemic Precautions for Front Line Workers
Date:5/14/2009

WASHINGTON, May 14 /PRNewswire-USNewswire/ -- If the H1N1 pandemic flu follows the pattern of the 1918 Great Pandemic it could come back with more vigor in a second wave next fall. In 1918, three separate recurrences of influenza followed each other with unusual rapidity, resulting in 3 explosive pandemic waves within a year's time. Dr. Thomas O'Brien, Vice President of the Alliance for the Prudent Use of Antibiotics and Microbiology Lab Director at Brigham and Women's Hospital stated this concern on May 14th before a Congressional Subcommittee, chaired by Congressman Stephen Lynch from the 9th district of Massachusetts.

Congressman Lynch called the hearing to consider how to protect federal workers who are first responders during flu epidemics. "I want to be sure we have good procedures in place to ensure the safety of federal workers and the public at large."

The work of APUA is given a special relevance to this danger by recent evidence that secondary bacterial infection was a major contributor to the 1918 influenza death rate and by recent changes in methicillin-resistant Staphylococcus aureus (MRSA). Because of overuse of related antibiotics, MRSA has spread widely in the community in recent years and on multiple occasions has acquired resistance to vancomycin, the drug that has been relied on for treating it. "MRSA will thus be a very likely major contributor to the mortality of future influenza infections, and preventing its further acquisition of antibiotic resistances is necessary to keep those infections from becoming untreatable," according to Dr. O'Brien of APUA.

The best defense is to ensure funding for strong state and federal public health programs, said Dr. O'Brien. He complimented Dr. Richard Besser, acting Director of the CDC and Dr. Alfred DeMaria, Director of Communicable Disease Control of the Massachusetts Department of Public Health for their epidemiology investigations and effective communications during the influenza outbreak in April and May. He emphasized the importance of disease tracking programs and the need for simple but critical everyday hygiene measures such as vigorous hand washing with soap and water or alcohol gels for all citizens. For surface disinfection APUA recommends soap and water or use of bleach and alcohol antiseptics rather than those that contain antibacterial agents such as triclosan that could select for antibiotic resistance. Emphasis for front-line workers and the general public should be on the proven protections of good hygiene and hand washing and not on an unproven need for facemasks. Facemasks are currently only recommended for healthcare professionals with prolonged exposure to patients diagnosed with H1N1.

Dr. O'Brien cautioned against unnecessary or over use of antibiotics and antivirals, such over use leaves us without effective antiviral or antibiotic drugs when the need is greatest.

APUA is an international public health organization based in Boston with chapters in 61 countries; Dr. Stuart B. Levy is President of APUA and a Professor at Tufts Medical School. APUA's mission is to control drug resistance and preserve the power of antibiotics, through research and education worldwide. For more information please visit our website at www.APUA.org.


'/>"/>
SOURCE Alliance for the Prudent Use of Antibiotics (APUA)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CEO Addresses Tennessee Business Leaders About Developing Pandemic and Business Continuity Plans
3. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
4. New Report Says a Pandemic is Overdue, But Companies and Nations are ill Prepared to Cope With the Impact
5. Report highlights inadequate pandemic planning as a threat to EU security
6. AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic
7. Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E
8. Vical Expands Clinical Testing of DNA Vaccine Against H5N1 Pandemic Influenza
9. CEO Addresses Georgia Business Leaders About Developing Pandemic and Business Continuity Plans
10. iJET Unveils 2007 Year-in-Review Report on Avian Influenza and Pandemic Planning
11. Flu Pandemic: Is the U.S. Ready?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... ... May 27, 2017 , ... From May 21-23, hearing healthcare professionals gained ... was held at the Marriott Syracuse Downtown Hotel in Syracuse, New York. , ... of independent hearing healthcare providers to help them stay ahead in the industry. At ...
(Date:5/26/2017)... ... May 26, 2017 , ... Mediaplanet is proud to ... campaign in USA Today, which will educate readers on how to take care of ... a large focus is placed on melanoma. Dancing with the Stars professional, Witney Carson, ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs ... on May 30th and 31st at The Four Seasons Hotel Boston. , ... the life sciences, offering exclusive access to key decision makers who influence deal ...
(Date:5/26/2017)... ... ... Amir Qureshi, MD is the first physician in Arkansas to implant Nuvecta’s ... Nuvectra™ Algovita SCS System has been FDA approved as a treatment option for chronic ... introduce the most powerful SCS system and the only stretchable lead on the market. ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community ... healthiest seniors are located in the Midwest. With the average cost of healthcare rising ... are concerned with both the quality and affordability of where they live. An annual ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... , May 17, 2017  Bayer announced today ... portfolio will be presented at the 53 rd ... (ASCO), taking place June 2-6 in Chicago ... at ASCO span prostate, colorectal, liver and thyroid cancers, ... from the Phase II CHRONOS-1 trial of copanlisib in ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) announced today ... ended April 1, 2017 .   GAAP diluted earnings ... the prior year period as the sale of the ... non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue of ... terms.  Excluding the effects of blood screening and the ...
(Date:5/9/2017)... Ind. , May 9, 2017 Zimmer ... leader in musculoskeletal healthcare, today announced it has earned ... Employers of 2017" list. The Company was ranked among ... of Large Employers and Healthcare Equipment and Services. ... employers based on an anonymous, independent survey of over ...
Breaking Medicine Technology: